|
1
|
Gross TJ and Hunninghake GW: Idiopathic
pulmonary fibrosis. N Engl J Med. 345:517–525. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dempsey OJ and Miller D: Idiopathic
pulmonary fibrosis. BMJ. 347:f65792013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mahendran S and Sethi T: Treatments in
idiopathic pulmonary fibrosis: Time for a more targeted approach?
QJM. 105:929–934. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Villar A, Gasco MA and Alcaraz MJ:
Anti-inflammatory and anti-ulcer properties of
hypolaetin-8-glucoside, a novel plant flavonoid. J Pharm Pharmacol.
36:820–823. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gerdin B and Svensjö E: Inhibitory effect
of the flavonoid O-(beta-hydroxyethyl)-rutoside on increased
microvascular permeability induced by various agents in rat skin.
Int J Microcirc Clin Exp. 2:39–46. 1983.PubMed/NCBI
|
|
6
|
Agarwal OP: The anti-inflammatory action
of nepitrin, a flavonoid. Agents Actions. 12:298–302. 1982.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Clere N, Faure S, Martinez MC and
Andriantsitohaina R: Anticancer properties of flavonoids: Roles in
various stages of carcinogenesis. Cardiovasc Hematol Agents Med
Chem. 9:62–77. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Czyz J, Madeja Z, Irmer U, Korohoda W and
Hülser DF: Flavonoid apigenin inhibits motility and invasiveness of
carcinoma cells in vitro. Int J Cancer. 114:12–18. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shukla S and Gupta S: Apigenin-induced
cell cycle arrest is mediated by modulation of MAPK, PI3K-Akt and
loss of cyclin D1 associated retinoblastoma dephosphorylation in
human prostate cancer cells. Cell Cycle. 6:1102–1114. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nicholas C, Batra S, Vargo MA, Voss OH,
Gavrilin MA, Wewers MD, Guttridge DC, Grotewold E and Doseff AI:
Apigenin blocks lipopolysaccharide-induced lethality in vivo and
proinflammatory cytokines expression by inactivating NF-kappaB
through the suppression of p65 phosphorylation. J Immunol.
179:7121–7127. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Duarte S, Arango D, Parihar A, Hamel P,
Yasmeen R and Doseff AI: Apigenin protects endothelial cells from
lipopolysaccharide (LPS)-induced inflammation by decreasing
caspase-3 activation and modulating mitochondrial function. Int J
Mol Sci. 14:17664–17679. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang X, Wang G, Gurley EC and Zhou H:
Flavonoid apigenin inhibits lipopolysaccharide-induced inflammatory
response through multiple mechanisms in macrophages. PloS One.
9:e1070722014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liao Y, Shen W, Kong G, Lv H, Tao W and Bo
P: Apigenin induces the apoptosis and regulates MAPK signaling
pathways in mouse macrophage ANA-1 cells. PloS One. 9:e920072014.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kowalski J, Samojedny A, Paul M, Pietsz G
and Wilczok T: Effect of apigenin, kaempferol and resveratrol on
the expression of interleukin-1beta and tumor necrosis factor-alpha
genes in J774.2 macrophages. Pharmacol Rep. 57:390–394.
2005.PubMed/NCBI
|
|
15
|
Wang J, Liao Y, Fan J, Ye T, Sun X and
Dong S: Apigenin inhibits the expression of IL-6, IL-8 and ICAM-1
in DEHP-stimulated human umbilical vein endothelial cells and in
vivo. Inflammation. 35:1466–1476. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lampronti I, Borgatti M, Vertuani S,
Manfredini S and Gambari R: Modulation of the expression of the
proinflammatory IL-8 gene in cystic fibrosis cells by extracts
deriving from olive mill waste water. Evid Based Complement
Alternat Med. 2013:9606032013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Huang CS, Lii CK, Lin AH, Yeh YW, Yao HT,
Li CC, Wang TS and Chen HW: Protection by chrysin, apigenin and
luteolin against oxidative stress is mediated by the Nrf2-dependent
up-regulation of heme oxygenase 1 and glutamate cysteine ligase in
rat primary hepatocytes. Arch Toxicol. 87:167–178. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Han JY, Ahn SY, Kim CS, Yoo SK, Kim SK,
Kim HC, Hong JT and Oh KW: Protection of apigenin against
kainate-induced excitotoxicity by anti-oxidative effects. Biol
Pharm Bull. 35:1440–1446. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jin BH, Qian LB, Chen S, Li J, Wang HP,
Bruce IC, Lin J and Xia Q: Apigenin protects endothelium-dependent
relaxation of rat aorta against oxidative stress. Eur J Pharmacol.
616:200–205. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ricupero DA, Poliks CF, Rishikof DC, Kuang
PP and Goldstein RH: Apigenin decreases expression of the
myofibroblast phenotype. FEBS Lett. 506:15–21. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wojcik KA, Skoda M, Koczurkiewicz P, Sanak
M, Czyż J and Michalik M: Apigenin inhibits TGF-β1 induced
fibroblast-to-myofibroblast transition in human lung fibroblast
populations. Pharmacol Rep. 65:164–172. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tarnell EB, Oliver BL, Johnson GM, Watts
FL and Thrall RS: Superoxide anion production by rat neutrophils at
various stages of bleomycin-induced lung injury. Lung. 170:41–50.
1992. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Oury TD, Thakker K, Menache M, Chang LY,
Crapo JD and Day BJ: Attenuation of bleomycin-induced pulmonary
fibrosis by a catalytic antioxidant metalloporphyrin. Am J Respir
Cell Mol Biol. 25:164–169. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kinnula VL, Fattman CL, Tan RJ and Oury
TD: Oxidative stress in pulmonary fibrosis: A possible role for
redox modulatory therapy. Am J Respir Crit Care Med. 172:417–422.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kuwano K, Nakashima N, Inoshima I,
Hagimoto N, Fujita M, Yoshimi M, Maeyama T, Hamada N, Watanabe K
and Hara N: Oxidative stress in lung epithelial cells from patients
with idiopathic interstitial pneumonias. Eur Respir J. 21:232–240.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bellocq A, Azoulay E, Marullo S, Flahault
A, Fouqueray B, Philippe C, Cadranel J and Baud L: Reactive oxygen
and nitrogen intermediates increase transforming growth
factor-beta1 release from human epithelial alveolar cells through
two different mechanisms. Am J Respir Cell Mol Biol. 21:128–136.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Salvemini D, Riley DP and Cuzzocrea S: SOD
mimetics are coming of age. Nat Rev Drug Discov. 1:367–374. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Piguet PF, Ribaux C, Karpuz V, Grau GE and
Kapanci Y: Expression and localization of tumor necrosis
factor-alpha and its mRNA in idiopathic pulmonary fibrosis. Am J
Pathol. 143:651–655. 1993.PubMed/NCBI
|
|
29
|
Yara S, Kawakami K, Kudeken N, Tohyama M,
Teruya K, Chinen T, Awaya A and Saito A: FTS reduces
bleomycin-induced cytokine and chemokine production and inhibits
pulmonary fibrosis in mice. Clin Exp Immunol. 124:77–85. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Bhatia M, Zemans RL and Jeyaseelan S: Role
of chemokines in the pathogenesis of acute lung injury. Am J Respir
Cell Mol Biol. 46:566–572. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Martin TR and Matute-Bello G: Experimental
models and emerging hypotheses for acute lung injury. Crit Care
Clin. 27:735–752. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Anscher MS: Targeting the TGF-beta1
pathway to prevent normal tissue injury after cancer therapy.
Oncologist. 15:350–359. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wilson MS, Madala SK, Ramalingam TR,
Gochuico BR, Rosas IO, Cheever AW and Wynn TA: Bleomycin and
IL-1beta-mediated pulmonary fibrosis is IL-17A dependent. J Exp
Med. 207:535–552. 2010. View Article : Google Scholar : PubMed/NCBI
|
